Background
==========

MD is a serious lymphoproliferative disease in chickens caused by MDV and characterized by transformation of T cells that cause tumors in various organs including liver, spleen, gonads, heart, peripheral nerves, skin and muscle \[[@B1]-[@B3]\]. Chickens with MD exhibit over-expression of Hodgkin\'s disease antigen CD30 (CD30^hi^) that makes it a natural model for studying the initiation and progression of CD30^hi^lymphomas \[[@B4]\]. MDV is an alphaherpesvirus belonging to the *Mardivirus*genus which contains three members: MDV-1, MDV-2 and HVT (herpesvirus of turkeys) \[[@B5]-[@B7]\]. According to Calnek *et al*. \[[@B8],[@B9]\], MDV, like other herpesviruses, goes through a complex life cycle that includes cytolytic and latent phases in host cells. An early cytolytic infection is started at 2-7dpi characterized by the virus particles expressing large amounts of the early protein pp38. Subsequently, a latent phase is initiated at around 7-10dpi with the MDV genome persisting in the host cells. Following latency, a late cytolytic phase causes inflammation and transformation of latently infected lymphocytes into tumor cells and is triggered between 14-21dpi \[[@B8],[@B9]\]. During the first cytolytic phase, MDV first uses B cells as a target for its replication before targeting activated CD4^+^T cells to enable a persistent latent infection \[[@B10]-[@B12]\].

Two highly inbred chicken lines 6~3~and 7~2~, sub-lines of lines 6 and 7, have been bred since 1939 with line 6~3~chickens resistant to MD and line 7~2~chickens susceptible to MD \[[@B13]\]. To better understand the mechanisms underlying MD-resistance and -susceptibility, several studies have been made to ascertain the differences between these two chicken lines. A much higher virus copy number was observed in line 7 chickens indicating varying levels of virus replication \[[@B14]\]. Different proportions of CD4^+^T cells and CD8^+^T cells were found in MD-resistant and -susceptible chickens when infected by MDV. In MD-susceptible birds, as the CD4^+^T cells increased in number, the number of CD8^+^T cells decreased; the opposite occurred in MD-resistant chickens \[[@B15]\]. Lymphocyte surface markers such as Ly-4, Bu-1 and Th-1, were present in different levels in these two chicken lines \[[@B16],[@B17]\]. The expression of some cytokines, such as IL6 and IL18, was also found to differ between line 6 and line 7 chickens\[[@B18]\]. From an epigenetic perspective, differences in promoter DNA methylation levels between line 6~3~and line 7~2~chickens have been found in several candidate genes \[[@B19]\].

With the development of functional genomics technologies, some progress has been made towards investigating the mechanism of MD-resistance in a genome-wide manner. Quantitative trait loci associated with MD-resistance or -susceptibility have been mapped to chromosomes 1, 5, 7, 9, 15, 18, 26, Z, E21 and E16 \[[@B20]-[@B23]\]. Also, through the use of chicken immune-specific microarrays, immunoglobulin genes have been shown to have a higher expression in MD-resistant chicken lines as compared to MD-susceptible chicken lines \[[@B24]\]. However, the exact mechanisms behind resistance and susceptibility to MD are still unknown.

Researchers at the Avian Disease and Oncology Laboratory (ADOL, East Lansing, MI, USA) have developed nineteen recombinant congenic strains (RCS) with varying phenotypic traits from lines 6~3~and 7~2~to further investigate the mechanisms of MD-resistance and - susceptibility \[[@B13],[@B25]\]. One of these strains, RCS-M, which was developed from line 6~3~and line 7~2~and possesses around 87% genetic background of line 6~3~, is genetically closer to the resistant line 6~3~. Our previous study of tumor incidence rates induced by a partially attenuated very virulent plus (vv+) strain of MDV (648A, passage 40) in the different RCSs revealed that while only 0-3% of line 6~3~chickens and up to 100% of the line 7~2~chickens developed tumors after MDV infection, about 40% of RCS-M chickens developed tumors (Data not shown). Because of this intermediate response of RCS-M to MDV infection, it is suitable for us to use these three chicken lines to investigate the mechanism of MD-resistance and susceptibility. We performed a temporal trancriptome analysis with spleen samples from line 6~3~, 7~2~and RCS-M chickens before and after MDV infection at 5dpi, 10dpi and 21dpi. Our main objective is to build on the current understanding of Marek\'s disease pathogenesis and immune response to MDV, and this genome-wide approach is used for this purpose. To our knowledge, this is the first comprehensive study combining a chicken line having intermediate resistance to MD together with highly-resistant and susceptible lines to more precisely identify the possible genetic factors behind MD resistance and susceptibility.

Results
=======

Temporal Gene Expression Profiles of line 6~3~, line 7~2~and line M chickens in MDV Challenge Experiment
--------------------------------------------------------------------------------------------------------

To find genes that may be involved in the MD-resistance and -susceptibility, we performed transcriptome analysis using three chicken lines with different phenotypes after MDV infection to find the host genes with different reactions to virus infection. We chose 5dpi, 10dpi and 21dpi to represent the critical phases of virus progression to study gene expression changes induced in the different chicken lines.

We conducted an initial quality assessment of our dataset to remove outliers (see Methods). Principal component analysis (PCA) was used to compare the global gene expression profiles of these three chicken lines. The preliminary PCA plot indicated broad differences between the three chicken lines with lines 6~3~and RCS-M clustering together and distinct from line 7~2~chickens (Figure [1](#F1){ref-type="fig"}). Data normalization and differential gene expression analysis was performed using the limma package in R (for details see Methods). In order to minimize transcriptional variations owing to growth and other developmental differences between the three chicken lines, individuals were paired by line and dpi and comparisons carried out between infected and non-infected individuals. The p-values were then corrected for multiple comparisons using the Benjamini-Hochberg FDR calculation procedure \[[@B26]\]. To detect the host response to MDV infection, we compared the gene expression level of the infected samples to non-infected control samples at the same time point. Differentially expressed gene lists were obtained using a criteria of P \< 0.05, FDR \< 0.5 and \|logFC\| \> 1.5.

![**A three-dimensional PCA plot of 64 individuals indicating broad transcriptional similarities between line 6~3~and RCS-M that are both markedly distinct from line 7~2~**.](1471-2164-12-501-1){#F1}

Our significant gene lists consisted of a total of 11779 genes in the three chicken lines across three time points that included some virus genes contained in the microarray (Additional file [1](#S1){ref-type="supplementary-material"}. Table S1). As our focus was on the host response to MDV infection, we excluded the MDV genes from further analysis reducing our total gene number to 11694 (Table [1](#T1){ref-type="table"}). Notably, no gene was found differentially expressed in line 7~2~at 5dpi using the above criteria. However, when validating the microarray results with qPCR, we found several genes significantly changed by MDV infection in line 7~2~at 5dpi (Additional file [2](#S2){ref-type="supplementary-material"}. Figure S1).

###### 

Number of genes differentially expressed after MDV infection

  ----------- ------------------------------ ------------------------------ --------------------------- ------- ------- -------
              **line 6~3~(Inf. Vs. Non.)**   **line 7~2~(Inf. Vs. Non.)**   **RCS-M (Inf. Vs. Non.)**                   
                                                                                                                        
              **+**                          **-**                          **+**                       **-**   **+**   **-**
                                                                                                                        
  **5dpi**    777                            651                            0                           0       707     680
  **10dpi**   708                            660                            823                         691     791     572
  **21dpi**   573                            585                            1007                        1088    567     814
  ----------- ------------------------------ ------------------------------ --------------------------- ------- ------- -------

Genes with differential expression were termed with P \< 0.05, \|LogFC\|\>1.5 and FDR \< 0.5. +: up-regulated after MDV infection; -: down-regulated after MDV infection.

Pathway analysis to find the networks and biofunctions involved in MDV infection
--------------------------------------------------------------------------------

To study the networks and biofunctions enriched in the differentially expressed genes after MDV infection, we used the IPA system to analyze genes sets. We first used the raw probe names from the microarray as the input data set and found less than 25% of the probes were compatible with IPA. Therefore, we used data mining to map the probe names to homologs from other species that could be used by IPA (for details see Methods). The mapped homologs of these ESTs are shown in Additional file [3](#S3){ref-type="supplementary-material"}. Table S2.

Detailed analyses of the networks and biofunctions affected by MDV in the different chicken lines across different time points were performed to understand the host responses to MDV infection. The top 5 networks influenced by MDV infection in each chicken line at three time points are shown in Table [2](#T2){ref-type="table"}. From these networks we can see that during various stages of the MDV life cycle (5dpi, 10dpi and 21dpi), the virus has a broad influence on host gene expression in all chicken lines. A large number of genes involved in metabolism, tissue development, gene expression and the cell cycle were changed by MDV infection in all chicken lines which indicated broad similarities in the host response to MDV infection. However, we also found some unique networks among these chicken lines, such as, cardiac arrhythmia and cardiovascular disease related networks found only in line 7~2~. On the other hand, some immune-related networks such as cell-mediated immune response and antigen presentation were only found in line 6~3~and RCS-M but not in line 7~2~. These are the specific responses to MDV infection which may be related to the genetic basis of MD-resistance and -susceptibility.

###### 

Enriched networks at different time points of MDV infection in different chicken lines

  ---------------------------------------------------------------------------------------------------------------
  Lines    Time\    Score   Focus\      Top Functions
           points           Molecules   
  -------- -------- ------- ----------- -------------------------------------------------------------------------
  L6~3~    5dpi     46      29          Digestive System Development and Function, Hepatic System\
                                        Development and Function, Organ Development

                    36      25          Skeletal and Muscular System Development and Function, Tissue\
                                        Morphology, Lipid Metabolism

                    35      25          Amino Acid Metabolism, Small Molecule Biochemistry, Cellular\
                                        Compromise

                    28      21          Carbohydrate Metabolism, Lipid Metabolism, Small Molecule\
                                        Biochemistry

                    24      20          Drug Metabolism, Endocrine System Development and Function, Lipid\
                                        Metabolism

           10dpi    36      25          Lipid Metabolism, Small Molecule Biochemistry, Vitamin and Mineral\
                                        Metabolism

                    30      21          Infection Mechanism, Visual System Development and Function,\
                                        Dermatological Diseases and Conditions

                    30      21          Molecular Transport, Cellular Movement, Cell Cycle

                    27      22          Neurological Disease, Carbohydrate Metabolism, Lipid Metabolism

                    26      19          Organismal Injury and Abnormalities, Infection Mechanism, Infectious\
                                        Disease

           21dpi    39      28          Cell Morphology, Cellular Function and Maintenance, Cell Death

                    34      22          Cardiovascular System Development and Function, Organismal\
                                        Development, Tissue Development

                    27      19          Carbohydrate Metabolism, Small Molecule Biochemistry, Cellular\
                                        Assembly and Organization

                    24      17          Cell-To-Cell Signaling and Interaction, Cell-mediated Immune\
                                        Response, Cellular Development

                    22      16          Lipid Metabolism, Small Molecule Biochemistry, Behavior

                                        

  L7~2~    10dpi    29      21          Cardiac Arrythmia, Cardiovascular Disease, Genetic Disorder

                    27      22          Cellular Assembly and Organization, Cellular Compromise, Free\
                                        Radical Scavenging

                    26      19          Cell-To-Cell Signaling and Interaction, Cellular Growth and\
                                        Proliferation, Skeletal and Muscular System Development and Function

                    24      18          Cell Morphology, Connective Tissue Development and Function,\
                                        Skeletal and Muscular System Development and Function

                    22      17          Infection Mechanism, Cardiovascular System Development and\
                                        Function, Organismal Development

           21dpi    38      27          Cell Morphology, Connective Tissue Development and Function,\
                                        Skeletal and Muscular System Development and Function

                    32      24          Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry

                    31      24          Embryonic Development, Tissue Development, Cell Cycle

                    31      24          Cell Morphology, Skeletal and Muscular System Development and\
                                        Function, Connective Tissue Development and Function

                    23      20          Connective Tissue Disorders, Genetic Disorder, Cellular Assembly and\
                                        Organization

                                        

  RCS- M   5dpi     32      22          Cell Morphology, Cellular Development, Cell Death

                    32      22          Cellular Assembly and Organization, Cell Morphology, Cellular\
                                        Development

                    30      21          Cell Morphology, Cellular Development, Skeletal and Muscular System

                                        Development and Function

                    28      20          Amino Acid Metabolism, Small Molecule Biochemistry, Drug\
                                        Metabolism

                    24      18          Inflammatory Disease, Renal and Urological Disease, Amino Acid\
                                        Metabolism

           10dpi    34      23          Carbohydrate Metabolism, Lipid Metabolism, Small Molecule\
                                        Biochemistry

                    31      21          Antigen Presentation, Cell-To-Cell Signaling and Interaction, Cellular\
                                        Function and Maintenance

                    29      20          Molecular Transport, Drug Metabolism, Lipid Metabolism

                    21      16          Carbohydrate Metabolism, Drug Metabolism, Small Molecule\
                                        Biochemistry

                    20      16          Dermatological Diseases and Conditions, Genetic Disorder,\
                                        Immunological Disease

           21dpi    33      23          Cell Morphology, Cellular Assembly and Organization, Cell-To-Cell\
                                        Signaling and Interaction

                    26      19          Connective Tissue Development and Function, Skeletal and Muscular\
                                        System Development and Function, Tissue Morphology

                    24      18          Carbohydrate Metabolism, Small Molecule Biochemistry, Organismal\
                                        Functions

                    24      23          Cell Death, Gene Expression, Cellular Function and Maintenance

                    23      18          Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry
  ---------------------------------------------------------------------------------------------------------------

\*The genes input in IPA software were obtained using P \< 0.05, \|LogFC\|\>1.5 and FDR\<0.5.

Identification of genes related with MD-resistance and -susceptibility
----------------------------------------------------------------------

Utilizing the varying characteristics of these chicken lines, we attempted to identify genes associated with MD-resistance and -susceptibility from pair-wise comparisons. We make the following observations about differentially expressed genes obtained from our analysis. Genes differentially expressed after MDV infection and having similar trends in line 6~3~and RCS-M but not in line 7~2~are likely to be related to MD-resistance; conversely, genes showing similar trends in line 7~2~and RCS-M but not in line 6~3~are possibly related to MD-susceptibility (Figure [2A](#F2){ref-type="fig"}). Genes differentially expressed after MDV infection in all three chicken lines are likely indicators of a common host response to virus infection. Finally, genes that are differentially expressed only in one chicken line could be part of a line-specific host response to virus infection (Figure [2A](#F2){ref-type="fig"}).

![**Venn diagram of the differentially expressed genes after MDV infection in different chicken lines at three time points showing the number of genes that are related to MD-resistance and -susceptibility**. A. Schema showing the gene sets related to MD-resistance and-susceptibility. R: genes related to MD-resistance; S: genes related to MD-susceptibility; U: line specific genes; N: genes with no definition. B. 10 days post infection. C. 21 days post infection. Line 6~3~.non: non-infected control of line 6~3~chickens; Line 63.inf: infected line 6~3~chickens; Line 7~2~.non: non-infected control of line 7~2~chickens; Line 72.inf: infected line 7~2~chickens; RCS-M.non: non-infected control of RCS-M; RCS M.inf: infected RCS-M chicken.](1471-2164-12-501-2){#F2}

From the above intuition, we were able to narrow the list of putative genes contributing to resistance (resistant genes) to 78 and 30 and the number of genes possibly associated with susceptibility (susceptible genes) to 78 and 43 at 10dpi, 21dpi respectively (Figure [2B-D](#F2){ref-type="fig"}). For some of the putative resistant genes, the fold change after MDV infection in RCS-M is about half or less compared to line 6~3~suggesting an additive effect of these genes in resistance (Additional file [4](#S4){ref-type="supplementary-material"}. Table S3). We can also find several genes that show a similar behaviour in the susceptible gene lists (Additional file [4](#S4){ref-type="supplementary-material"}. Table S3). This is consistent with the intermediate tumor incidence rates we observed in RCS-M chickens.

Although we were able to limit the number of putative resistant and susceptible genes, it is still a difficult task to determine the most important genes. By further analysing the networks associated with these genes, we found several genes involved in a large number of biofunctions (Additional file [5](#S5){ref-type="supplementary-material"}. Table S4). This indicated the importance of these genes to MD resistance or susceptibility even though they may not have very high fold changes. We defined high-confidence genes as those involved in more than 5 biofunctions to obtain high-confidence gene lists important for MD-resistance or -susceptibility (Table [3](#T3){ref-type="table"}). The differentially expressed genes at the various time points were different indicating different mechanisms involved in the host response. At 10 dpi several interleukin genes were present among the putative susceptible genes such as IL8, IL17A and IL12RB2. The NOS2 gene, which can catalyze the generation of NO (nitric oxide), was also found in the putative MD-susceptible gene list.

###### 

Genes from MD-resistant and -susceptible gene lists enriched in more than 5 biofunctions

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  T.Point   R./S.   Genes     +/-   No.\   P.Name         S. Name        Description
                                    Bio.                                 
  --------- ------- --------- ----- ------ -------------- -------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  10dpi     R.      GNAQ      \-    39     \*002455       AJ851735       Q5F3B5 : (Q5F3B5) Hypothetical protein

                                                                         

            R.      PRKG1     \-    33     \*015981       BU421057       Q9Z0Z0 : (Q9Z0Z0) cGMP-dependent protein kinase 1, beta isozyme (CGK 1 beta) (cGKI-beta)

                                                                         

            R.      CD8A      \+    27     \*007686       CR390735       XP_420863 : gi:50747402:ref:XP_420863.1: PREDICTED: similar to CD8 alpha chain \[Gallus gallus\]

                                                                         

            R.      RGS4      \-    27     A_87_P021537   BX950639       Gallus gallus finished cDNA, clone ChEST606e8. \[BX950639\]

                                                                         

            R.      RARB      \-    25     A_87_P008918   X56674         Chicken mRNA for retinoic acid binding protein beta isoform. \[X56674\]

                                                                         

            R.      HAS3      \+    12     \*013355       BU278152       Q8CEB9 : (Q8CEB9) Mus musculus 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732404L04 product:similar to DG42III

                                                                         

            R.      SPINK5    \-    12     \*005267       CR353088       P10184 : gi:1708509:sp:P10184:IOV7_CHICK Ovoinhibitor precursor &gt;gnl:BL_ORD_ID:146450 gi:212485:gb:AAA48994.1: ovoinhibitor

                                                                         

            R.      SULF2     \-    10     A_87_P022688   BX934216       Gallus gallus finished cDNA, clone ChEST442e20. \[BX934216\]

                                                                         

            R.      COL14A1   \-    9      A_87_P008851   X70793         G.domesticus mRNA for collagen XIV (longer splice variant). \[X70793\]

                                                                         

            R.      SCN4B     \-    9      A_87_P021873   BX935954       Gallus gallus finished cDNA, clone ChEST430l23. \[BX935954\]

                                                                         

            R.      WISP1     \-    9      A_87_P009711   DQ003338       Gallus gallus WNT1 inducible signaling pathway protein 1 (WISP-1) mRNA, complete cds. \[DQ003338\]

                                                                         

            R.      AHNAK     \-    5      \*004305       BX935083       NP_033773 : gi:61743961:ref:NP_033773.1: AHNAK nucleoprotein isoform 1 \[Mus musculus\]

                                                                         

            R.      P4HA2     \-    5      A_87_P007103   TC198023       Q8BU53 (Q8BU53) Mus musculus 2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230038K10 product:procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide, full insert sequence, p

                                                                         

            S.      NOS2      \+    64     A_87_P009073   U46504         Chicken macrophage nitric oxide synthase mRNA. \[U46504\]

                                                                         

            S.      IL8       \-    58     \*010230       Y14971         O73912 : (O73912) K60 protein precursor (CXC chemokine K60)

                                                                         

            S.      IL17A     \+    53     A_87_P035017   AY920750       Gallus gallus interleukin 17 mRNA, complete cds. \[AY920750\]

                                                                         

            S.      CTLA4     \+    47     \*019882       DN853042       XP_421960 : gi:50750341:ref:XP_421960.1: PREDICTED: similar to costimulatory molecule B7 receptor CD152 \[Gallus gallus\]

                                                                         

            S.      IL12RB2   \+    23     \*000640       AJ621939       Q5GR16 : (Q5GR16) Interleukin 12 receptor beta 2 (Fragment)

                                                                         

            S.      PLK1      \+    20     \*001748       AJ720598       Q5ZJ36 : (Q5ZJ36) Hypothetical protein

                                                                         

            S.      ROR1      \-    13     \*000634       AJ620298       Q705C2 : (Q705C2) Tyrosine kinase orphan receptor 1

                                                                         

            S.      LECT2     \-    11     \*009802       M29449         O88803 : (O88803) Leukocyte cell-derived chemotaxin 2 precursor (Chondromodulin II) (ChM-II)

                                                                         

            S.      ABCA8     \-    6      \*016305       BU440826       XP_415691 : gi:50757881:ref:XP_415691.1: PREDICTED: similar to ATP-binding cassette, sub-family A, member 10; ATP-binding cassette A10 \[Gallus gallus\]

                                                                         

            S.      TSPAN8    \-    6      \*004228       BX934864       XP_416096 : gi:50728338:ref:XP_416096.1: PREDICTED: similar to Tm4sf3 protein \[Gallus gallus\]

                                                                         

            S.      COL5A2    \-    6      A_87_P001489   TC224310       Q86XF6 (Q86XF6) COL5A2 protein, partial (5%) \[TC224310\]

                                                                         

            R.      MMP9      \-    63     A_87_P037769   AF222690       Gallus gallus 75 kDa gelatinase mRNA, complete cds. \[AF222690\]

                                                                         

  21dpi     R.      SFTPA1    \+    38     \*000489       AF411083       Q90XB2 : (Q90XB2) Surfactant protein A precursor

                                                                         

            R.      FBXW4     \-    6      \*015952       BU419266       Q9JMJ2 : (Q9JMJ2) F-box/WD-repeat protein 4 (F-box and WD-40 domain protein 4) (Hagoromo protein)

                                                                         

            R.      CPN1      \-    5      \*006641       CR387490       Q9EQV8 : (Q9EQV8) Carboxypeptidase N, polypeptide 1, 50kD

                                                                         

            S.      CD28      \+    50     \*010136       X67915         P31043 : (P31043) T-cell-specific surface glycoprotein CD28 homolog precursor (CHT28)

                                                                         

            S.      CHRM4     \-    37     A_87_P009241   NM_001031191   Gallus gallus cholinergic receptor, muscarinic 4 (CHRM4), mRNA \[NM_001031191\]

                                                                         

            S.      F10       \-    29     \*009605       D00844         P25155 : (P25155) Coagulation factor × precursor (Stuart factor) (Virus activating protease) (VAP)

                                                                         

            S.      WNT7A     \-    27     A_87_P038155   AB045629       Gallus gallus mRNA for Wnt-7a, complete cds. \[AB045629\]

                                                                         

            S.      FMN2      \+    12     A_87_P005690   TC203559       AF218942 formin 2-like protein {Homo sapiens;}, partial (28%) \[TC203559\]

                                                                         

            S.      ATF6      \-    8      A_87_P023703   BX931991       Gallus gallus finished cDNA, clone ChEST222o13. \[BX931991\]

                                                                         

            S.      GLO1      \-    6      \*004233       BX934880       XP_419481 : gi:50740506:ref:XP_419481.1: PREDICTED: similar to glyoxylase 1; glyoxalase 1 \[Gallus gallus\]

                                                                         

            S.      OPN4      \-    5      \*002725       AY882944       XP_421494 : gi:50749124:ref:XP_421494.1: PREDICTED: similar to Opsin 4 (Melanopsin) \[Gallus gallus\]

                                                                         

            S.      ITGBL1    \-    5      \*016603       BU449144       Q4VBJ0 : (Q4VBJ0) Integrin, beta-like 1
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

T.Point: time point; No. Bio.: number of biofunctions involved; P.Name: Probe Name; S.Name: Systematic Name; R.: resistant genes; S.: susceptible genes; +: up-regulated; -:down-regulated.

Validation of the microarray results by real-time quantitative PCR
------------------------------------------------------------------

To validate the microarray results, we designed primers for some high-confidence genes such as *CD8α*, *CTLA4, IL8*and *USP18*and some other genes chosen at random, such as *CD8β*, *GHR*, *TNFRSF6B*and *MMP2*. Since a reference gene with stable expression is essential to avoid distortions in qPCR, the two genes *GAPDH*and *ACTB*are commonly used as internal reference for doing qPCR of MDV infected samples \[[@B24],[@B27]\]. In our validation, we first used both genes as internal references to see if there were any distortions and found no differences (Additional file [6](#S6){ref-type="supplementary-material"}. Figure S2). Therefore, *GAPDH*was chosen as the internal reference. We also designed primers that span introns to further avoid the influence of DNA contamination. As shown in Additional file [2](#S2){ref-type="supplementary-material"}. Figure S1, we were able to validate most of the genes that are differentially expressed. Also, comparable expression profiles were observed for most of the validated genes in the microarray and qPCR (Table [4](#T4){ref-type="table"}) which further suggested that the gene expression profiles from the microarray are reliable.

###### 

Validation of microarray results by quantitative PCR

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Genes        Probe Name in Micro-array   Time\    Gene expression fold change after MDV infection in each lines\                                                        
                                           points   (Inf./Non.)                                                                                                           
  ------------ --------------------------- -------- ---------------------------------------------------------------- ------------ ------------ ------------- ------------ ------------
                                           5dpi     1.02                                                             ***1.45***   2.85         ***4.07***    1.41         1.29

  *CTLA-4*     \*019882                    10dpi    2.31                                                             ***3.37***   ***3.29***   ***13.68***   ***3.56***   ***7.02***

                                           21dpi    0.62                                                             ***2.05***   ***3.07***   2.03          1.27         1.44

                                                                                                                                                                          

                                           5dpi     1.46                                                             1.05         1.41         1.19          1.52         0.85

  *CD8α*       \*007686                    10dpi    ***2.92***                                                       ***2.33***   1.51         1.35          ***3.90***   2.80

                                           21dpi    1.08                                                             ***3.13***   ***0.35***   ***0.05***    1.24         2.01

                                                                                                                                                                          

                                           5dpi     1.17                                                             1.14         1.07         0.97          1.14         0.78

  *CD8β*       A_87_P008699                10dpi    ***1.87***                                                       ***2.86***   1.03         2.05          ***1.86***   2.30

                                           21dpi    1.42                                                             ***3.31***   ***0.32***   ***0.04***    1.10         ***2.03***

                                                                                                                                                                          

                                           5dpi     1.24                                                             ***3.37***   4.09         4.13          1.43         1.68

  *USP18*      \*005670                    10dpi    2.07                                                             2.15         ***4.87***   ***5.55***    2.53         0.58

                                           21dpi    0.98                                                             11.89        ***3.28***   4.54          ***2.73***   ***5.99***

                                                                                                                                                                          

                                           5dpi     1.00                                                             2.85         5.67         ***9.36***    1.12         ***4.17***

  *TNFRSF6B*   \*003404                    10dpi    ***5.03***                                                       ***9.47***   ***5.52***   ***11.46***   2.75         2.35

                                           21dpi    1.54                                                             ***5.27***   ***4.28***   ***9.14***    1.00         ***6.85***

                                                                                                                                                                          

                                           5dpi     1.00                                                             0.64         0.60         ***0.28***    ***0.62***   ***0.29***

  *MMP2*       A_87_P009159                10dpi    0.78                                                             0.89         ***0.63***   0.93          ***0.54***   0.62

                                           21dpi    0.88                                                             1.10         ***0.22***   ***0.02***    0.82         1.16

                                                                                                                                                                          

                                           5dpi     1.00                                                             0.72         1.04         ***0.18***    1.71         0.91

  *IL8*        \*010230                    10dpi    ***8.28***                                                       0.66         ***3.01***   ***0.19***    ***4.25***   ***0.10***

                                           21dpi    18.51                                                            2.22         ***0.46***   ***0.02***    0.81         ***2.59***

                                                                                                                                                                          

                                           5dpi     1.00                                                             ***3.14***   1.00         ***0.45***    1.85         0.81

  *GHR*        A_87_P009190                10dpi    ***8.57***                                                       ***1.25***   0.24         ***1.82***    1.00         ***0.53***

                                           21dpi    1.54                                                             ***1.56***   0.40         0.59          1.00         ***2.76***
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The numbers here represent the fold change of gene expression after MDV infection. The numbers equal to 1.00 means the expression level doesn\'t change after MDV infection. The numbers \> 1.00 means the expression level is increased after MDV infection while numbers \< 1.00 indicate that the expression level is reduced after MDV infection. The numbers in bold and italic are statistically significant (P \< 0.05).

Discussion
==========

There have been several studies looking at gene expression changes related to disease in general \[[@B28]-[@B30]\] and MD in particular \[[@B24],[@B27],[@B31]-[@B34]\], although results tend to vary a lot. MD is a complex disease with the disease phenotype in susceptible individuals depending on the location and frequency of tumors. Any single gene with differential expression cannot fully explain the phenomenon of host resistance or susceptibility. Therefore, we tried to use a genome-wide approach to build on the current understanding of Marek\'s disease pathogenesis and immune response to MDV. Upon close examination of the transcriptional responses, dramatically increased numbers of significant genes were observed at 10dpi in RCS-M and at 21dpi in line 7~2~at lower FDR levels (FDR \< 0.2) which indicated a strongly enhanced transcriptional response. At a more relaxed FDR level (FDR \< 0.5), we find comparable numbers of differentially expressed genes at 5, 10 and 21dpi in line 6~3~and RCS-M. Line 7~2~has similar numbers of significant genes at 10dpi but there is a definite increase in the transcriptional response at 21dpi with close to twice as many differentially expressed genes. However, even at this level, we do not find any significantly expressed genes at 5dpi in line 7~2~(FDR\<0.5), indicating a much muted transcriptional response (Table [1](#T1){ref-type="table"}).

Over the years, several attempts have been made to identify the gene profiles that change as a result of MDV infection. For example, using microarray analysis, studies have identified some genes related to MDV infection by using different chicken lines and MDV strains \[[@B24],[@B31]-[@B34]\]. When chicken embryo fibroblasts were infected with MDV, genes related to inflammation, cell-growth and differentiation and antigen presentation, such as *MIP*, *IL-13R*, *MHC I*and *MHC II*were induced both at 2dpi and 4dpi \[[@B33]\]. In contrast, in spleen tissue, several other genes were found to be affected at an early stage, including *TLR-15*, *IL-6*and *Mx1*\[[@B31]\]. In chickens with major histocompatibility complex (MHC)-associated MD resistance, the immunoglobulin genes *IgG*and *IgM*were differentially expressed after MDV infection at 7dpi and 14dpi\[[@B24]\], whereas in lines 6 and 7 from ADOL, that carry the same MHC haplotype (B^2^) but differ in their response to MDV infection\[[@B35]\], various alloantigens like Ly-4 \[[@B16]\] and Bu-1 \[[@B17]\] were differentially expressed. Linkage and association studies as well as integrated analyses using genetic mapping and microarrays have revealed some genes that may be responsible for MD progression or resistance, such as *GH*, *IFNγ*and *SULT*\[[@B27]\]. However, it is difficult to find a consensus amongst these studies due to variation in experimental parameters such as, virus strain or *in vitro*derived samples. By using a genome-wide approach and three chicken lines with varying resistance to MD, we were able to generate a comprehensive list of candidate genes that can be used for studying MD-resistance and susceptibility. Besides finding some genes that were reported in previous studies, such as *Mx1*, we also found several genes that have not been reported before in this context, such as *CD8α, IL8, USP18*, and *CTLA4*. *CD8α*, present in the putative resistant gene list at 10dpi, codes a surface glycoprotein expressed on a subpopulation of cytotoxic T lymphocytes (CTLs) \[[@B36]\], which binds to the α3 domain or membrane-proximal domain of most of the known HLA class I molecules to enhance CTL activation \[[@B37]-[@B41]\]. It has been shown that *CD8α*was up-regulated by MDV infection at the early cytolytic stage (4dpi and 7dpi), whereas *IgM*and *CD3*were down-regulated \[[@B34]\]. These are similar to our microarray results, the slight difference being possibly due to the differences in virus strains and genetic background of the chickens. The *CD8α*gene was significantly up-regulated at 10dpi in the MD-resistant chicken line (line 6~3~) and RCS-M, but down-regulated in the MD-susceptible chicken line (line 7~2~). In chickens vaccinated against MDV an increase of CD8α cells was found after MDV infection compared to unvaccinated chickens \[[@B32]\]. The vaccinated birds were phenotypically similar to line 6~3~and hence, this result is consistent with our finding. The above evidence, taken all together, leads us to speculate that *CD8α*plays an important role in MD resistance. The induction of *CD8α*gene may result from an increase of the CD8^+^T cells that eliminate MDV infected cells in the resistant chickens. However, this scenario needs further validation.

In contrast, CTL-associated antigen-4 (*CTLA-4*), present in our putative susceptible gene list at 10dpi, is a member of the immunoglobulin superfamily expressed on the surface of an activated T cell \[[@B42]\]. It has been reported that the knockout of *CTLA-4*resulted in a lymphoproliferative disorder and death in mice, which indicated a very important role of CTLA-4 in negative regulation of T cell activation \[[@B43]\]. The blockade of the CTLA-4 pathway results in a rejection of tumor \[[@B44],[@B45]\], indicating that a lower *CTLA-4*expression may be important for antitumor response. Therefore, in humans, a current strategy of immunotherapy focuses on the blockade of the *CTLA-4*pathway \[[@B46],[@B47]\]. A higher expression of *CTLA-4*was detected at lymphoma lesions in MD-susceptible chickens at 21dpi, although no significant difference was found in the whole tissue \[[@B48]\]. Importantly, a similar result existed in our data: the fold change of *CTLA-4*at 10dpi after MDV infection is much less in line 6~3~than in line 7~2~and RCS-M (Table [4](#T4){ref-type="table"}), indicating a lower level of *CTLA-4*involved in antitumor immune response.

In addition to the above genes, some networks and biofunctions were also observed to be different between MD-resistant and susceptible chickens. It is interesting to note that most of the differentially expressed genes were not enriched in biofunctions of immune related diseases, but with other diseases or metabolism. This is consistent with the fact that apart from the generation of tumors, MD-susceptible chickens also exhibit weight loss, paralysis and other symptoms. However, some immune response-related biofunctions were enriched only in line 6~3~and RCS-M chickens. It was thought for a long time that tumor cells have no antigen and this enables them to escape the host immune system. While the finding of the melanoma antigen in the late 1980\'s shed light on the role of immune system to fight against tumors \[[@B49]\], the tumor cells are known to also have immunosuppressive agents that help them evade detection and killing by the immune system \[[@B50],[@B51]\]. The networks related to immune response found in line 6~3~chickens, suggests that in these chickens the immune system is activated to counteract the development of tumor. In contrast, the transformed cells in susceptible chickens are able to escape the natural resistance of the immune system to generate tumors, although at present it is still unclear if this is due to a larger initial damage to the immune system \[[@B52]\] or the immunosuppression induced by MDV in line 7~2~chickens. NOS2 is an enzyme that catalyzes the generation of NO \[[@B53]\] which in turn increases the virulence of MDV by immunosuppression \[[@B54]\]. However, it has also been shown that NO has inhibitory effects on MDV replication \[[@B55]\] and NO production in MDV-infected susceptible chickens (MHC, B^13^B^13^) is the lowest in comparison to MD-infected resistant birds (MHC, B^19^B^19^) \[[@B55],[@B56]\]. Interestingly, we found that the *NOS2*gene was up-regulated in susceptible chicken lines. Therefore, it remains to be seen whether the up-regulation of *NOS2*in line 7~2~could induce immunosuppression and increase the risk of tumor generation in MD-susceptible chickens. The above results indicate that different immune response in resistant and susceptible chickens lead to the vastly different responses to MDV infection.

To minimize transcriptional variations and take full advantage of a similar genetic background in the inbred lines, we paired birds by line and dpi, respectively, and tested the difference between infected and non-infected individuals. This procedure not only led us to identify the genes most likely related to MD resistance and susceptibility, but also revealed a common broad influence of MDV infection on the hosts. By using IPA to analyze differentially expressed gene sets, we found focused pathways enriched in metabolism, tissue development, gene expression and cell cycle along with other immune-related pathways preferentially enriched in resistant chickens. These results suggested possible mechanisms and specific genes related to MD-resistance or -susceptibility. We hypothesized that there are four possible causes behind MD-resistance: some genes activated in resistant chickens can (i) cause loss of the MDV receptor, (ii) help to clear infected cells, (iii) affect the viral life cycle or (iv) prevent transformation of infected cells. Our observations and previous research have showed that the virus load in both resistant and susceptible chickens was similar at early stages of infection \[[@B18],[@B57]\], suggesting the presence of receptors for MDV in both resistant and susceptible chickens. Thus, the latter three of the aforementioned possibilities are more likely to be the main reasons for MD-resistance although it is not easy to say which of these play a big role in non-MHC associated resistance.

Conclusions
===========

Using a comprehensive genome-wide study of gene expression in chicken lines with varying resistance to MD, we were able to identify pathways and genes that may be involved in MD-resistance and susceptibility. Phenotypic similarities between the chicken lines enabled us to narrow the list of putative genes to 108 genes associated with MD-resistance and 121 genes associated with susceptibility. Combining network analysis with differential gene expression analysis helped uncover high-confidence genes such as *CD8α*, *IL8*, *USP18*, and *CTLA-4*and several immune-related biofunctions with potentially important consequences to MDV infection. Our findings add to the current understanding of the mechanism behind resistance and susceptibility to MD while expanding the scope of future studies with a comprehensive list of putative genes. Our approach also underlines the importance of comprehensive functional studies to gain valuable biological insight into the genetic factors behind complex disease.

Methods
=======

Sample Collection for Microarray
--------------------------------

Three inbred lines of White Leghorn (line 6~3~, line 7~2~and RCS-M) were divided into two treatment groups each containing 60 chickens. One group from each line was infected with a partially attenuated very virulent strain (vv^+^) of MDV-648A passage 40 \[[@B1]\], at day 5 after hatch, intra-abdominally at a viral dosage of 500 plaque-forming units (PFU) per chick. The other group was not infected. The viral-challenge experiment was conducted in the BL-2 facility at ADOL. Four chickens from each group were euthanized at 5dpi (cytolytic infection period), 10dpi (latency period) and 21dpi (reactivation period), respectively. Spleen samples were collected and stored in RNAlater solution (Qiagen, Valencia, CA, USA) at -20°C until RNA extraction. All the experimental chickens were managed and euthanized following ADOL\'s Guidelines for Animal Care and Use (revised April, 2005) and the Guide for the Care and Use of Laboratory Animals published by Institute for Laboratory Animal Research (ILAR Guide) in 1996 (<http://www.nap.edu/openbook.php?record_id=5140>).

RNA Extraction
--------------

Approximately 30\~50mg spleen tissues were homogenized in TRizol Reagent (Invitrogen, Frederick, MD, USA), and total RNA extraction was performed according to the manufacturer\'s instructions (Invitrogen, Frederick, MD, USA). Total RNA was purified using the RNAeasy mini column (Qiagen, Valencia, CA, USA) and contaminant DNA was digested by DNase I (Qiagen, Valencia, CA, USA). RNA concentration was assessed using Nanodrop ND-1000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA) and RNA quality determined by 2100 Bioanalyzer (Agilent, Foster City, CA, USA).

Microarray Experiment Design, Hybridization and Analysis
--------------------------------------------------------

Custom Agilent 4 × 44K chicken microarrays were used in this study. The 4 × 44K chicken arrays were designed based on the whole chicken genome sequence and consist of 42,034 probes \[[@B58]\]. Four biological replicates of each group were carried out at each time point. RNA was labelled using the Agilent Quick-Amp labelling kit (Agilent Technologies, Santa Clara, CA, USA). In two of the four replicates of each experimental group, the infected samples were labelled with Cy3 and the uninfected two were labelled with Cy5. A total of 825 ng of Cy3 and Cy5 labelled cDNAs were then hybridized to the 4 × 44K Agilent chicken arrays. Following stringency washes, slides were scanned on an Agilent G2505B microarray scanner and the resulting image files analyzed with Agilent Feature Extraction software (version 9.5.1). All procedures were carried out according to the manufacturer\'s protocols. After the microarray analysis was performed in three chicken lines at three time points, we first tested for the presence of outliers (JMP Genomics, Version 9). Parallel plots and PCA revealed the presence of outliers in our datasets, which were subsequently removed. A parallel plot subsequently indicated that the log~2~intensities had similar distributions across all remaining arrays (Additional file [7](#S7){ref-type="supplementary-material"}. Figure S3). After the initial quality assessment step we performed linear modelling using the limma package in R to find differentially expressed genes. Dye bias was removed by normalizing within array using loess normalization \[[@B59]\] and normalization between arrays was carried out using quantile normalization \[[@B60]\]. The p-values were corrected for multiple comparisons using the Benjamini-Hochberg FDR calculation procedure \[[@B26]\]. We compared age-matched individuals from the same line before and after infection with MDV at three time points of disease progression. All the array data discussed in this publication have been deposited in NCBI\'s Gene Expression Omnibus (Yu *et al*., 2010) and are accessible through GEO Series accession number GSE24017 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24017>).

Data Mining and Network Analysis
--------------------------------

The expressed sequence tags (ESTs) specific to microarray probes were mapped to proteins or protein homologs with GenBank names, Swissprot, pfam or RefSeq accession numbers using the BioMart data mining system via Sigenae (Details found on <http://www.sigenae.org>). Proteins with the identity of 40% or more were considered to be homologs \[[@B61]\]. In case of multiple proteins mapping to a probe, proteins with the highest identity were used to create a unique mapping. The resultant list was then analyzed using IPA to detect the enrichment of biofunctions and networks. Core analysis was performed in IPA using significantly expressed genes from the statistical analysis based on the Ingenuity Knowledge Base with the reference set \"Genes + Endogenous Chemicals\".

Quantitative Real-time RT-PCR
-----------------------------

RNA samples for quantitative real-time PCR were used for first strand cDNA synthesis using 1 *μg*of total RNA by SuperScript™ II Reverse Transcriptase (Invitrogen, Frederick, MD, USA) with oligo (dT)~12-18~primers (Invitrogen, Frederick, MD, USA). Samples were then analyzed with real time RT-PCR using an iCycler iQ PCR system (Bio-Rad, Hercules, CA, USA). The real time RT-PCR reactions were performed in a final volume of 20 *μ*l with the QuantiTect SYBR Green PCR Kit (Qiagen, Valencia, CA, USA) according to the manufacturer\'s instructions. Each group has 4 biological replicates with 3 replicates for one reaction and each reaction was repeated twice. The mRNA expression was normalized against the housekeeping gene *GAPDH*(glyceraldehyde-3-phosphate dehydrogenase). The primers for all the genes analyzed are in Additional file [8](#S8){ref-type="supplementary-material"}. Table S5. All steps of our Q-PCR validation, which include RNA extraction, cDNA synthesis, reference gene selection, Q-PCR procedures, and data analysis were performed according to the *Minimum Information for Publication of Quantitative PCR Experiments*(MIQE) guidelines \[[@B62]\]
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###### Additional file 1

**Table S1. Number of genes differentially expressed after MDV infection including MDV genes**. This table contains the number of genes that are differentially expressed after MDV infection which including all the genes that were shown in the microarray like MDV genes. Genes with differential expression were termed with p \< 0.05, LogFC\>1.5 and FDR \< 0.5. +: up-regulated after MDV infection; -: down-regulated after MDV infection.

###### 

Click here for file

###### Additional file 2

**Figure S1. Validation of microarray data by Q-PCR**. This figure showing the Q-PCR validation result of the genes that shown significant different expression after MDV infection in three time points (5dpi, 10dpi, and 21dpi). Line 6~3~.non: non-infected control of line 6~3~chickens; Line 63.inf: infected line 6~3~chickens; Line 7~2~.non: non-infected control of line 7~2~chickens; Line 72.inf: infected line 7~2~chickens; non: non-infected control of chicken; inf: infected RCS-M chicken. n = 4 for each line. \**P*\< 0.05, \*\**P*\< 0.01.
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Click here for file

###### Additional file 3

**Table S2. Homologs of chicken ESTs from BioMart**. This table includes the homologs that were converted from the chicken ESTs on the microarray. The data mining was down on BioMark (details see <http://www.sigenae.org>).

###### 

Click here for file

###### Additional file 4

**Table S3. Possible MD-resistant and susceptible gene lists at 10dpi and 21dpi**. This table showed the possible candidates for MD-resistance and susceptibility at 10dpi and 21dpi. The gene lists were chosen by the following criteria: Genes differentially expressed after MDV infection and having similar trends in line 63 and RCS-M but not in line 72 are likely to be related to MD-resistance; conversely, genes showing similar trends in line 72 and RCS-M but not in line 63 are possibly related to MD-susceptibility.

###### 
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###### Additional file 5

**Table S4. Biofunction enrichment of the MD-resistant and susceptible genes at 10dpi and 21dpi**. The genes that are listed as possible MD-resistant and -susceptible genes were used to do the IPA analysis. This table showed the biofunctions that were enriched by these genes at 10dpi and 21dpi.
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###### Additional file 6

**Figure S2. Stability test of the internal reference**. *ACTB*gene was added to normalize the gene expression when doing the Q-PCR experiment to monitor the stability of the Q-PCR result when using *GAPDH*as the internal control. A similar ratio shown in both normalization method indicated a stabilized system of the Q-PCR.
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###### Additional file 7

**Figure S3. A parallel plot of kernel densities shows similar distribution of log2 intensities in all arrays after normalization**.
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###### Additional file 8

**Table S5. Primers for validation of microarray results by quantitative PCR**.
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